Newsroom|Lundbeck US

Advancing Brain Health Treatments: Making the Case for a Neuroscience Center of Excellence at FDA

Advancing Brain Health Treatments: Making the Case for a Neuroscience Center of Excellence at FDA

Experts discuss why establishing a Neuroscience Center of Excellence at the FDA is important.

0

ABOUT THE NEWSROOM

Here you will find media contacts, plus the latest news, stories and insights from Lundbeck US. Lundbeck is a global pharmaceutical company solely focused on the brain, and our 900+ U.S. employees are committed to improving the lives of people affected by psychiatric and neurological disorders.

Science

Perspective

our-impact

press-release

Tweets by LundbeckUS

Lundbeck launches a phase II study for potential new treatment of multiple system atrophy

Lundbeck launches a phase II study for potential new treatment of multiple system atrophy

0

Bold Initiative Aims to Identify Communities in Need of Greater Mental Health Supports Amid the Pandemic

Bold Initiative Aims to Identify Communities in Need of Greater Mental Health Supports Amid the Pandemic

0

New Analysis Finds St. Louis County, Missouri Had Highest Percentage of Population Screen At-Risk for PTSD of All Large Counties in 2020 and Early 2021

New Analysis Finds St. Louis County, Missouri Had Highest Percentage of Population Screen At-Risk for PTSD of All Large Counties in 2020 and Early 2021

0

Otsuka and Lundbeck Announce FDA Acceptance of Supplemental New Drug Application; Receive Priority Review for Treatment of Schizophrenia in Adolescents

Otsuka and Lundbeck Announce FDA Acceptance of Supplemental New Drug Application; Receive Priority Review for Treatment of Schizophrenia in Adolescents

0

Video: Mental Health Experts Discuss Suicide Prevention Strategies

Video: Mental Health Experts Discuss Suicide Prevention Strategies

0